Clinical TrialsSearch results
Number of results: 988
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- TBD
- Taletrectinib is to be indicated for the treatment of adult Japanese patients with ROS1 or NTRK fusi
- Nakayama Tomoko
- 2022-01-13
Other
- The Intraoperative Landiolol for Intracranial Aneurysm Surgery Trials
- Tachyarrhythmia
- The Intraoperative Landiolol for Intracranial Aneurysm Surgery Trials Group
- 2007-12-15
Other
- Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
- tachyarrhythmia
- JL-Knight Study Group
- 2007-12-27
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A phase II study of stereotactic body radiation therapy in patients with T1N0M0 non-small cell lung cancer (JCOG0403)
- T1N0M0 non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- Accelerated fractionation vs. conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study (JCOG0701)
- T1-2N0M0 glottic cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-05
Recruiting
- A study of KK4277 in Healthy Volunteers, Patient with Systemic Lupus Erythematosus, and Patient with Cutaneous Lupus Erythematosus
- Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus
- Kinoshita Jun
- 2022-06-12
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- Phase II study of rituximab in patients with severe systemic lupus erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16